Search
InsiderInsights.com

Rosenblum Mark J (1329154)

Rosenblum Mark J has been a registered insider at 3 firms since 2005. As Chief Financial Officer at Flex Pharma, Inc., Rosenblum Mark J last made a transaction on 11/20/2025. As Chief Financial Officer at Ayala Pharmaceuticals Inc, Rosenblum Mark J last made a transaction on 10/24/2013. As Chief Financial Officer at HEMOBIOTECH INC, Rosenblum Mark J last made a transaction on 11/20/2005.

(FLKS, SLRX)

Titles: VP,FO,CFO

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
2 100% 581% 581% 205 1 Year 2 0% -- -- --
2 100% 701% 701% 759 9 Month 2 0% -- -- --
2 100% 1107% 1107% 236 6 Month 2 0% -- -- --
2 50% 1359% 1359% 2,804 3 Month 2 0% -- -- --
3 33% 2% -1% 25 1 Month 3 0% -- -- --
3 67% 6% 4% 23 1 Week 3 0% -- -- --
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
-- -- -- -- -- 1 Year -- -- -- -- --
-- -- -- -- -- 9 Month -- -- -- -- --
-- -- -- -- -- 6 Month -- -- -- -- --
-- -- -- -- -- 3 Month -- -- -- -- --
-- -- -- -- -- 1 Month -- -- -- -- --
-- -- -- -- -- 1 Week -- -- -- -- --
Scorecards Updated 1/7/2026 03:11 AM EST Latest Transaction Date: 11/20/2025
Average days between Transaction and Entered Dates: 2

Advaxis, Inc. (ADXS)

Titles: CFO

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
1 0% -11% -- -- 1 Year 1 0% -- -- --
1 0% -23% -- -- 9 Month 1 0% -- -- --
1 0% -32% -- -- 6 Month 1 0% -- -- --
1 100% 30% -- -- 3 Month 1 0% -- -- --
1 100% 3% -- -- 1 Month 1 0% -- -- --
1 100% 2% -- -- 1 Week 1 0% -- -- --
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
-- -- -- -- -- 1 Year -- -- -- -- --
-- -- -- -- -- 9 Month -- -- -- -- --
-- -- -- -- -- 6 Month -- -- -- -- --
-- -- -- -- -- 3 Month -- -- -- -- --
-- -- -- -- -- 1 Month -- -- -- -- --
-- -- -- -- -- 1 Week -- -- -- -- --
Scorecards Updated 1/7/2026 03:11 AM EST Latest Transaction Date: 10/24/2013
Average days between Transaction and Entered Dates: 4

HEMOBIOTECH, INC. (HMBT)

Titles: CFO

InsiderInsights.com Purchase Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Purchases
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
1 100% 12% -- -- 1 Year 1 0% -- -- --
1 0% -6% -- -- 9 Month 1 0% -17% -- --
1 100% 68% -- -- 6 Month 1 100% 50% -- --
1 100% 53% -- -- 3 Month 1 100% 33% -- --
1 100% 67% -- -- 1 Month 1 100% 13% -- --
1 0% -3% -- -- 1 Week 1 0% -11% -- --
InsiderInsights.com Sales Scorecard
Transaction Date
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
Time From
Sales
Nq Hit
Rate
Mean
Return
Median
Return
Range of
Returns
-- -- -- -- -- 1 Year -- -- -- -- --
-- -- -- -- -- 9 Month -- -- -- -- --
-- -- -- -- -- 6 Month -- -- -- -- --
-- -- -- -- -- 3 Month -- -- -- -- --
-- -- -- -- -- 1 Month -- -- -- -- --
-- -- -- -- -- 1 Week -- -- -- -- --
Scorecards Updated 11/12/2021 06:08 PM EST Latest Transaction Date: 11/20/2005
Average days between Transaction and Entered Dates: 3
© 2026 InsiderInsights.com